{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.ai-analytics.org/drug-product/57841-1150#drug","name":"Talicia","alternateName":"omeprazole magnesium, amoxicillin and rifabutin","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"57841-1150"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA213004"},{"@type":"PropertyValue","propertyID":"UNII","value":"804826J2HU|426QFE7XLK|1W306TDA6S"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"68c4e9dc-dbcf-4151-b6f7-5e4b9922b76f"}],"activeIngredient":"AMOXICILLIN, OMEPRAZOLE MAGNESIUM, RIFABUTIN","administrationRoute":["ORAL"],"dosageForm":"CAPSULE, DELAYED RELEASE","manufacturer":{"@type":"Organization","name":"RedHill Biopharma Ltd"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.ai-analytics.org/drug-approval/NDA213004","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68c4e9dc-dbcf-4151-b6f7-5e4b9922b76f","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57841-1150"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-09-27T09:27:43.104Z"}}